Kimia Biosciences (BOM:530313) Price-to-Tangible-Book : (As of Jun. 05, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Price-to-Tangible-Book?

As of today (2024-06-05), Kimia Biosciences's share price is ₹48.67. Kimia Biosciences's Tangible Book per Share of . 20 for the quarter that ended in . 20 was ₹0.00. Hence, Kimia Biosciences's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Kimia Biosciences's Price-to-Tangible-Book or its related term are showing as below:

BOM:530313's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.33
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Kimia Biosciences's share price is ₹48.67. Kimia Biosciences's Book Value per Sharefor the quarter that ended in . 20 was ₹0.00. Hence, Kimia Biosciences's P/B Ratio of today is .

Kimia Biosciences Price-to-Tangible-Book Historical Data

The historical data trend for Kimia Biosciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Price-to-Tangible-Book Chart

Kimia Biosciences Annual Data

Trend

Price-to-Tangible-Book

Kimia Biosciences Semi-Annual Data

Price-to-Tangible-Book

Competitive Comparison of Kimia Biosciences's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Price-to-Tangible-Book falls into.

Kimia Biosciences Price-to-Tangible-Book Calculation

Kimia Biosciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: . 20 )
	=	48.67	/
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Kimia Biosciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines